Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
10.2M
-
Number of holders
-
26
-
Total shares
-
1.07M
-
Shares change
-
-61.2K
-
Total reported value, excl. options
-
$4.95M
-
Value change
-
-$297K
-
Put/Call ratio
-
0.16
-
Number of buys
-
6
-
Number of sells
-
-12
-
Price
-
$4.64
Significant Holders of PolyPid Ltd. - Ordinary Shares, no par value (PYPD) as of Q2 2022
30 filings reported holding PYPD - PolyPid Ltd. - Ordinary Shares, no par value as of Q2 2022.
PolyPid Ltd. - Ordinary Shares, no par value (PYPD) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07M shares
of 10.2M outstanding shares and own 10.49% of the company stock.
Largest 10 shareholders include UBS Group AG (279K shares), SILVERARC CAPITAL MANAGEMENT, LLC (162K shares), ALLIANCEBERNSTEIN L.P. (115K shares), MORGAN STANLEY (103K shares), VICTORY CAPITAL MANAGEMENT INC (95.8K shares), Raymond James Financial Services Advisors, Inc. (53.3K shares), JFG Wealth Management, LLC (39.1K shares), MEITAV DASH INVESTMENTS LTD (31.5K shares), SIMPLEX TRADING, LLC (30.1K shares), and CITADEL ADVISORS LLC (26.3K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.